← FDA DRUG APPROVALS

FDA ANDA · ANDA075107

PENTOXIFYLLINE

Sponsor: ANI PHARMS

APPLICATION
ANDA075107
TYPE
ANDA
ORIGINAL APPROVAL
1998-09-04
LATEST ACTION
2002-11-07
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PENTOXIFYLLINEDiscontinued
PENTOXIFYLLINE 400MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2002-11-07Manufacturing (CMC) · Supplement 4AP
2001-08-31Manufacturing (CMC) · Supplement 3AP
1999-03-22Manufacturing (CMC) · Supplement 2AP
1999-03-22Manufacturing (CMC) · Supplement 1AP
1998-09-04OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →